BioSpace News Archive

Genetown

Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies

Affinia Therapeutics, an innovative gene therapy company with a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies and a mission to develop transformative medicines for devastating diseases, today announced it has closed an oversubscribed $60 million Series A financing.

March 31, 2020
·
3 min read
BioMidwest

POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer

Predictive Oncology Inc. (NASDAQ: POAI) (“POAI” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced continued progress towards by its Helomics subsidiary towards the goal of developing an AI-driven predictive model of ovarian cancer (CancerQuest 2020).

March 31, 2020
·
7 min read
Xenon Pharmaceuticals Provides Corporate Update in the Context of COVID-19

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today provided a corporate update in the context of the developing situation with the COVID-19 pandemic.

March 31, 2020
·
14 min read
Biotech Bay

Data on Sagimet’s Lead Candidate TVB-2640 to be Presented at EASL ILC 2020

Phase 2 clinical data in NASH accepted for late-breaker oral presentation; preclinical data accepted for poster presentation

March 31, 2020
·
3 min read
Business

Chiesi USA increases support measures for employees, patients and community partners in response to COVID-19 pandemic

Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group, announced a range of new measures to support employees, patients and healthcare providers in response to the continuing COVID-19 pandemic.

March 31, 2020
·
6 min read
Pharm Country

EpiGentek Announces a New Antibody-Based Blood Test to Detect COVID-19 in as Little as 3 Minutes

EpiGentek, a NY-based biotechnology firm specializing in epigenetic assay products and services, has announced that in light of the ongoing COVID-19 global pandemic, it is launching a rapid serological test to detect for the disease.

March 31, 2020
·
2 min read
Biotech Beach

Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt

Keith Murphy, founder and Chief Executive Officer of Viscient Biosciences (“Viscient”), today is calling for a pause in the merger attempt of Organovo Holdings, Inc (“Organovo”), after Organovo failed to receive enough votes to consummate the merger.

March 31, 2020
·
6 min read
Rochester Regional Health Deploys Datos for Remote Monitoring of Patients and Staff at Risk of Coronavirus

Joint Project with Strategic Interests Implemented in Just 4 Days to Help Rochester Regional Protect At-Risk Health Workers and Remotely Monitor Suspected and Diagnosed COVID-19 Patients

March 31, 2020
·
5 min read
BioMidwest

Bravado Health releases COVID-19 tool to help hospitals and businesses connect with patients and employees

Bravado Health released a new screening and education tool to help hospitals and businesses keep their patients and employees informed during the spread of COVID-19, based on the latest CDC guidance.

March 31, 2020
·
1 min read
BioMidwest

Echosens and MetaPhy Health Collaborate to Expand Patient-Centered Care for Chronic Liver Conditions: Gastroenterology Specialists Improve Outcomes, Lower Costs & Enhance Practice Performance

Echosens, a high-technology company offering the FibroScan family of products, announces its collaboration with MetaPhy Health to support turn-key, comprehensive chronic disease management services to gastroenterology practices for their patients with fatty liver disease.

March 31, 2020
·
3 min read